A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism.

Portland, OR -- (ReleaseWire) -- 09/25/2014 --A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.

Get Access to full report at:
http://www.reportsandintelligence.com/global-therapeutic-vaccines-2014-2018-market

TechNavio's analysts forecast the Global Therapeutic Vaccines market to grow at a CAGR of 62.81 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.

TechNavio's report, the Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions:

- Americas
- EMEA
- APAC

Key Vendors:

- Agenus Inc.
- Bavarian Nordic A/S.
- Dendreon Corp.
- GlaxoSmithKline plc
- Novartis International AG

Other Prominent Vendors:

- AFFiRiS AG.
- Argos Therapeutics Inc.
- Celldex Therapeutics Inc.
- CEL-SCI Corp.
- Cytos Biotechnology AG
- GlobeImmune Inc.
- NewLink Genetics Corp.
- NovaRx Corp.
- Oncothyreon Inc.
- TVAX Biomedical Inc.
- TapImmune Inc.
- Vical Inc.
- Vaccinogen Inc.

Similar Report:
NeuroVive Pharmaceutical AB (NVP): http://www.reportsandintelligence.com/neurovive-pharmaceutical-ab-nvp-pharmaceuticals-and-healthcare-deals-and-alliances-profile-market